Global Equine Influenza Vaccine Market Growth 2025-2031
The global Equine Influenza Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Equine influenza (horse flu) is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virus: equine-1 (H7N7) and equine-2 (H3N8). The World Organisation for Animal Health now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe. (Elton and Cullinane, 2013; Paillot, 2014; Slater et al., 2013[4]). The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Equine Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Equine Influenza Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Equine Influenza Vaccine sales for 2025 through 2031. With Equine Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Equine Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Equine Influenza Vaccine market?
What factors are driving Equine Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Influenza Vaccine market opportunities vary by end market size?
How does Equine Influenza Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Equine influenza (horse flu) is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virus: equine-1 (H7N7) and equine-2 (H3N8). The World Organisation for Animal Health now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe. (Elton and Cullinane, 2013; Paillot, 2014; Slater et al., 2013[4]). The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Equine Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Equine Influenza Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Equine Influenza Vaccine sales for 2025 through 2031. With Equine Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Equine Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liquid
- Powder
- Home
- Pet Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim Vetmedica
What is the 10-year outlook for the global Equine Influenza Vaccine market?
What factors are driving Equine Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Influenza Vaccine market opportunities vary by end market size?
How does Equine Influenza Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lifebuoys Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lifebuoys by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lifebuoys by Country/Region, 2020, 2024 & 2031
2.2 Lifebuoys Segment by Type
2.2.1 Inherent life Lifebuoys
2.2.2 Inflatable life Lifebuoys
2.3 Lifebuoys Sales by Type
2.3.1 Global Lifebuoys Sales Market Share by Type (2020-2025)
2.3.2 Global Lifebuoys Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lifebuoys Sale Price by Type (2020-2025)
2.4 Lifebuoys Segment by Application
2.4.1 Industrial and Commercial
2.4.2 Recreational
2.5 Lifebuoys Sales by Application
2.5.1 Global Lifebuoys Sale Market Share by Application (2020-2025)
2.5.2 Global Lifebuoys Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lifebuoys Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lifebuoys Breakdown Data by Company
3.1.1 Global Lifebuoys Annual Sales by Company (2020-2025)
3.1.2 Global Lifebuoys Sales Market Share by Company (2020-2025)
3.2 Global Lifebuoys Annual Revenue by Company (2020-2025)
3.2.1 Global Lifebuoys Revenue by Company (2020-2025)
3.2.2 Global Lifebuoys Revenue Market Share by Company (2020-2025)
3.3 Global Lifebuoys Sale Price by Company
3.4 Key Manufacturers Lifebuoys Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lifebuoys Product Location Distribution
3.4.2 Players Lifebuoys Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIFEBUOYS BY GEOGRAPHIC REGION
4.1 World Historic Lifebuoys Market Size by Geographic Region (2020-2025)
4.1.1 Global Lifebuoys Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lifebuoys Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lifebuoys Market Size by Country/Region (2020-2025)
4.2.1 Global Lifebuoys Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lifebuoys Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lifebuoys Sales Growth
4.4 APAC Lifebuoys Sales Growth
4.5 Europe Lifebuoys Sales Growth
4.6 Middle East & Africa Lifebuoys Sales Growth
5 AMERICAS
5.1 Americas Lifebuoys Sales by Country
5.1.1 Americas Lifebuoys Sales by Country (2020-2025)
5.1.2 Americas Lifebuoys Revenue by Country (2020-2025)
5.2 Americas Lifebuoys Sales by Type (2020-2025)
5.3 Americas Lifebuoys Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lifebuoys Sales by Region
6.1.1 APAC Lifebuoys Sales by Region (2020-2025)
6.1.2 APAC Lifebuoys Revenue by Region (2020-2025)
6.2 APAC Lifebuoys Sales by Type (2020-2025)
6.3 APAC Lifebuoys Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lifebuoys by Country
7.1.1 Europe Lifebuoys Sales by Country (2020-2025)
7.1.2 Europe Lifebuoys Revenue by Country (2020-2025)
7.2 Europe Lifebuoys Sales by Type (2020-2025)
7.3 Europe Lifebuoys Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lifebuoys by Country
8.1.1 Middle East & Africa Lifebuoys Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lifebuoys Revenue by Country (2020-2025)
8.2 Middle East & Africa Lifebuoys Sales by Type (2020-2025)
8.3 Middle East & Africa Lifebuoys Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lifebuoys
10.3 Manufacturing Process Analysis of Lifebuoys
10.4 Industry Chain Structure of Lifebuoys
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lifebuoys Distributors
11.3 Lifebuoys Customer
12 WORLD FORECAST REVIEW FOR LIFEBUOYS BY GEOGRAPHIC REGION
12.1 Global Lifebuoys Market Size Forecast by Region
12.1.1 Global Lifebuoys Forecast by Region (2026-2031)
12.1.2 Global Lifebuoys Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lifebuoys Forecast by Type (2026-2031)
12.7 Global Lifebuoys Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Survitec
13.1.1 Survitec Company Information
13.1.2 Survitec Lifebuoys Product Portfolios and Specifications
13.1.3 Survitec Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Survitec Main Business Overview
13.1.5 Survitec Latest Developments
13.2 International Safety Products
13.2.1 International Safety Products Company Information
13.2.2 International Safety Products Lifebuoys Product Portfolios and Specifications
13.2.3 International Safety Products Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 International Safety Products Main Business Overview
13.2.5 International Safety Products Latest Developments
13.3 Viking Life-Saving Equipment
13.3.1 Viking Life-Saving Equipment Company Information
13.3.2 Viking Life-Saving Equipment Lifebuoys Product Portfolios and Specifications
13.3.3 Viking Life-Saving Equipment Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Viking Life-Saving Equipment Main Business Overview
13.3.5 Viking Life-Saving Equipment Latest Developments
13.4 Marine Safety Products
13.4.1 Marine Safety Products Company Information
13.4.2 Marine Safety Products Lifebuoys Product Portfolios and Specifications
13.4.3 Marine Safety Products Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Marine Safety Products Main Business Overview
13.4.5 Marine Safety Products Latest Developments
13.5 Aqua Life
13.5.1 Aqua Life Company Information
13.5.2 Aqua Life Lifebuoys Product Portfolios and Specifications
13.5.3 Aqua Life Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Aqua Life Main Business Overview
13.5.5 Aqua Life Latest Developments
13.6 Hansen Protection
13.6.1 Hansen Protection Company Information
13.6.2 Hansen Protection Lifebuoys Product Portfolios and Specifications
13.6.3 Hansen Protection Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hansen Protection Main Business Overview
13.6.5 Hansen Protection Latest Developments
13.7 H3O Water Sports
13.7.1 H3O Water Sports Company Information
13.7.2 H3O Water Sports Lifebuoys Product Portfolios and Specifications
13.7.3 H3O Water Sports Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 H3O Water Sports Main Business Overview
13.7.5 H3O Water Sports Latest Developments
13.8 Johnson Outdoors
13.8.1 Johnson Outdoors Company Information
13.8.2 Johnson Outdoors Lifebuoys Product Portfolios and Specifications
13.8.3 Johnson Outdoors Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Johnson Outdoors Main Business Overview
13.8.5 Johnson Outdoors Latest Developments
13.9 Kent Sporting Goods
13.9.1 Kent Sporting Goods Company Information
13.9.2 Kent Sporting Goods Lifebuoys Product Portfolios and Specifications
13.9.3 Kent Sporting Goods Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kent Sporting Goods Main Business Overview
13.9.5 Kent Sporting Goods Latest Developments
13.10 Mustang Survival
13.10.1 Mustang Survival Company Information
13.10.2 Mustang Survival Lifebuoys Product Portfolios and Specifications
13.10.3 Mustang Survival Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mustang Survival Main Business Overview
13.10.5 Mustang Survival Latest Developments
13.11 Stormy Lifejackets
13.11.1 Stormy Lifejackets Company Information
13.11.2 Stormy Lifejackets Lifebuoys Product Portfolios and Specifications
13.11.3 Stormy Lifejackets Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Stormy Lifejackets Main Business Overview
13.11.5 Stormy Lifejackets Latest Developments
13.12 Secumar
13.12.1 Secumar Company Information
13.12.2 Secumar Lifebuoys Product Portfolios and Specifications
13.12.3 Secumar Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Secumar Main Business Overview
13.12.5 Secumar Latest Developments
13.13 Spinlock
13.13.1 Spinlock Company Information
13.13.2 Spinlock Lifebuoys Product Portfolios and Specifications
13.13.3 Spinlock Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Spinlock Main Business Overview
13.13.5 Spinlock Latest Developments
13.14 SeaSafe Systems
13.14.1 SeaSafe Systems Company Information
13.14.2 SeaSafe Systems Lifebuoys Product Portfolios and Specifications
13.14.3 SeaSafe Systems Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SeaSafe Systems Main Business Overview
13.14.5 SeaSafe Systems Latest Developments
13.15 The Coleman Company
13.15.1 The Coleman Company Company Information
13.15.2 The Coleman Company Lifebuoys Product Portfolios and Specifications
13.15.3 The Coleman Company Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 The Coleman Company Main Business Overview
13.15.5 The Coleman Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lifebuoys Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lifebuoys by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lifebuoys by Country/Region, 2020, 2024 & 2031
2.2 Lifebuoys Segment by Type
2.2.1 Inherent life Lifebuoys
2.2.2 Inflatable life Lifebuoys
2.3 Lifebuoys Sales by Type
2.3.1 Global Lifebuoys Sales Market Share by Type (2020-2025)
2.3.2 Global Lifebuoys Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lifebuoys Sale Price by Type (2020-2025)
2.4 Lifebuoys Segment by Application
2.4.1 Industrial and Commercial
2.4.2 Recreational
2.5 Lifebuoys Sales by Application
2.5.1 Global Lifebuoys Sale Market Share by Application (2020-2025)
2.5.2 Global Lifebuoys Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lifebuoys Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lifebuoys Breakdown Data by Company
3.1.1 Global Lifebuoys Annual Sales by Company (2020-2025)
3.1.2 Global Lifebuoys Sales Market Share by Company (2020-2025)
3.2 Global Lifebuoys Annual Revenue by Company (2020-2025)
3.2.1 Global Lifebuoys Revenue by Company (2020-2025)
3.2.2 Global Lifebuoys Revenue Market Share by Company (2020-2025)
3.3 Global Lifebuoys Sale Price by Company
3.4 Key Manufacturers Lifebuoys Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lifebuoys Product Location Distribution
3.4.2 Players Lifebuoys Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIFEBUOYS BY GEOGRAPHIC REGION
4.1 World Historic Lifebuoys Market Size by Geographic Region (2020-2025)
4.1.1 Global Lifebuoys Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lifebuoys Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lifebuoys Market Size by Country/Region (2020-2025)
4.2.1 Global Lifebuoys Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lifebuoys Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lifebuoys Sales Growth
4.4 APAC Lifebuoys Sales Growth
4.5 Europe Lifebuoys Sales Growth
4.6 Middle East & Africa Lifebuoys Sales Growth
5 AMERICAS
5.1 Americas Lifebuoys Sales by Country
5.1.1 Americas Lifebuoys Sales by Country (2020-2025)
5.1.2 Americas Lifebuoys Revenue by Country (2020-2025)
5.2 Americas Lifebuoys Sales by Type (2020-2025)
5.3 Americas Lifebuoys Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lifebuoys Sales by Region
6.1.1 APAC Lifebuoys Sales by Region (2020-2025)
6.1.2 APAC Lifebuoys Revenue by Region (2020-2025)
6.2 APAC Lifebuoys Sales by Type (2020-2025)
6.3 APAC Lifebuoys Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lifebuoys by Country
7.1.1 Europe Lifebuoys Sales by Country (2020-2025)
7.1.2 Europe Lifebuoys Revenue by Country (2020-2025)
7.2 Europe Lifebuoys Sales by Type (2020-2025)
7.3 Europe Lifebuoys Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lifebuoys by Country
8.1.1 Middle East & Africa Lifebuoys Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lifebuoys Revenue by Country (2020-2025)
8.2 Middle East & Africa Lifebuoys Sales by Type (2020-2025)
8.3 Middle East & Africa Lifebuoys Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lifebuoys
10.3 Manufacturing Process Analysis of Lifebuoys
10.4 Industry Chain Structure of Lifebuoys
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lifebuoys Distributors
11.3 Lifebuoys Customer
12 WORLD FORECAST REVIEW FOR LIFEBUOYS BY GEOGRAPHIC REGION
12.1 Global Lifebuoys Market Size Forecast by Region
12.1.1 Global Lifebuoys Forecast by Region (2026-2031)
12.1.2 Global Lifebuoys Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lifebuoys Forecast by Type (2026-2031)
12.7 Global Lifebuoys Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Survitec
13.1.1 Survitec Company Information
13.1.2 Survitec Lifebuoys Product Portfolios and Specifications
13.1.3 Survitec Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Survitec Main Business Overview
13.1.5 Survitec Latest Developments
13.2 International Safety Products
13.2.1 International Safety Products Company Information
13.2.2 International Safety Products Lifebuoys Product Portfolios and Specifications
13.2.3 International Safety Products Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 International Safety Products Main Business Overview
13.2.5 International Safety Products Latest Developments
13.3 Viking Life-Saving Equipment
13.3.1 Viking Life-Saving Equipment Company Information
13.3.2 Viking Life-Saving Equipment Lifebuoys Product Portfolios and Specifications
13.3.3 Viking Life-Saving Equipment Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Viking Life-Saving Equipment Main Business Overview
13.3.5 Viking Life-Saving Equipment Latest Developments
13.4 Marine Safety Products
13.4.1 Marine Safety Products Company Information
13.4.2 Marine Safety Products Lifebuoys Product Portfolios and Specifications
13.4.3 Marine Safety Products Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Marine Safety Products Main Business Overview
13.4.5 Marine Safety Products Latest Developments
13.5 Aqua Life
13.5.1 Aqua Life Company Information
13.5.2 Aqua Life Lifebuoys Product Portfolios and Specifications
13.5.3 Aqua Life Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Aqua Life Main Business Overview
13.5.5 Aqua Life Latest Developments
13.6 Hansen Protection
13.6.1 Hansen Protection Company Information
13.6.2 Hansen Protection Lifebuoys Product Portfolios and Specifications
13.6.3 Hansen Protection Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hansen Protection Main Business Overview
13.6.5 Hansen Protection Latest Developments
13.7 H3O Water Sports
13.7.1 H3O Water Sports Company Information
13.7.2 H3O Water Sports Lifebuoys Product Portfolios and Specifications
13.7.3 H3O Water Sports Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 H3O Water Sports Main Business Overview
13.7.5 H3O Water Sports Latest Developments
13.8 Johnson Outdoors
13.8.1 Johnson Outdoors Company Information
13.8.2 Johnson Outdoors Lifebuoys Product Portfolios and Specifications
13.8.3 Johnson Outdoors Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Johnson Outdoors Main Business Overview
13.8.5 Johnson Outdoors Latest Developments
13.9 Kent Sporting Goods
13.9.1 Kent Sporting Goods Company Information
13.9.2 Kent Sporting Goods Lifebuoys Product Portfolios and Specifications
13.9.3 Kent Sporting Goods Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kent Sporting Goods Main Business Overview
13.9.5 Kent Sporting Goods Latest Developments
13.10 Mustang Survival
13.10.1 Mustang Survival Company Information
13.10.2 Mustang Survival Lifebuoys Product Portfolios and Specifications
13.10.3 Mustang Survival Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mustang Survival Main Business Overview
13.10.5 Mustang Survival Latest Developments
13.11 Stormy Lifejackets
13.11.1 Stormy Lifejackets Company Information
13.11.2 Stormy Lifejackets Lifebuoys Product Portfolios and Specifications
13.11.3 Stormy Lifejackets Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Stormy Lifejackets Main Business Overview
13.11.5 Stormy Lifejackets Latest Developments
13.12 Secumar
13.12.1 Secumar Company Information
13.12.2 Secumar Lifebuoys Product Portfolios and Specifications
13.12.3 Secumar Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Secumar Main Business Overview
13.12.5 Secumar Latest Developments
13.13 Spinlock
13.13.1 Spinlock Company Information
13.13.2 Spinlock Lifebuoys Product Portfolios and Specifications
13.13.3 Spinlock Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Spinlock Main Business Overview
13.13.5 Spinlock Latest Developments
13.14 SeaSafe Systems
13.14.1 SeaSafe Systems Company Information
13.14.2 SeaSafe Systems Lifebuoys Product Portfolios and Specifications
13.14.3 SeaSafe Systems Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SeaSafe Systems Main Business Overview
13.14.5 SeaSafe Systems Latest Developments
13.15 The Coleman Company
13.15.1 The Coleman Company Company Information
13.15.2 The Coleman Company Lifebuoys Product Portfolios and Specifications
13.15.3 The Coleman Company Lifebuoys Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 The Coleman Company Main Business Overview
13.15.5 The Coleman Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Influenza Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Equine Influenza Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 6. Global Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Equine Influenza Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Equine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Equine Influenza Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Equine Influenza Vaccine Sale by Application (2020-2025) & (K Doses)
Table 11. Global Equine Influenza Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Equine Influenza Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Equine Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Equine Influenza Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Equine Influenza Vaccine Sales by Company (2020-2025) & (K Doses)
Table 16. Global Equine Influenza Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Equine Influenza Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Equine Influenza Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Equine Influenza Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Equine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Equine Influenza Vaccine Products Offered
Table 22. Equine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Influenza Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Equine Influenza Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Equine Influenza Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Equine Influenza Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Equine Influenza Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Equine Influenza Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Equine Influenza Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Equine Influenza Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Equine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Equine Influenza Vaccine Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Equine Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Equine Influenza Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Equine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Equine Influenza Vaccine
Table 52. Key Market Challenges & Risks of Equine Influenza Vaccine
Table 53. Key Industry Trends of Equine Influenza Vaccine
Table 54. Equine Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Influenza Vaccine Distributors List
Table 57. Equine Influenza Vaccine Customer List
Table 58. Global Equine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Equine Influenza Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Equine Influenza Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Equine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Equine Influenza Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Equine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Equine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Equine Influenza Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Equine Influenza Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Equine Influenza Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Equine Influenza Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Zoetis Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Equine Influenza Vaccine Product Portfolios and Specifications
Table 74. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Merck Animal Health Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Equine Influenza Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Boehringer Ingelheim Vetmedica Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolios and Specifications
Table 84. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Boehringer Ingelheim Vetmedica Main Business
Table 86. Boehringer Ingelheim Vetmedica Latest Developments
Table 1. Equine Influenza Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Equine Influenza Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 6. Global Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Equine Influenza Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Equine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Equine Influenza Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Equine Influenza Vaccine Sale by Application (2020-2025) & (K Doses)
Table 11. Global Equine Influenza Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Equine Influenza Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Equine Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Equine Influenza Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Equine Influenza Vaccine Sales by Company (2020-2025) & (K Doses)
Table 16. Global Equine Influenza Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Equine Influenza Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Equine Influenza Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Equine Influenza Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Equine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Equine Influenza Vaccine Products Offered
Table 22. Equine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Influenza Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Equine Influenza Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Equine Influenza Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Equine Influenza Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Equine Influenza Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Equine Influenza Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Equine Influenza Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Equine Influenza Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Equine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Equine Influenza Vaccine Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Equine Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Equine Influenza Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Equine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Equine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Equine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Equine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Equine Influenza Vaccine
Table 52. Key Market Challenges & Risks of Equine Influenza Vaccine
Table 53. Key Industry Trends of Equine Influenza Vaccine
Table 54. Equine Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Influenza Vaccine Distributors List
Table 57. Equine Influenza Vaccine Customer List
Table 58. Global Equine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Equine Influenza Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Equine Influenza Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Equine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Equine Influenza Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Equine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Equine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Equine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Equine Influenza Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Equine Influenza Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Equine Influenza Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Equine Influenza Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Zoetis Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Equine Influenza Vaccine Product Portfolios and Specifications
Table 74. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Merck Animal Health Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Equine Influenza Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Boehringer Ingelheim Vetmedica Basic Information, Equine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolios and Specifications
Table 84. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Boehringer Ingelheim Vetmedica Main Business
Table 86. Boehringer Ingelheim Vetmedica Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Influenza Vaccine
Figure 2. Equine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Influenza Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Equine Influenza Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Equine Influenza Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Equine Influenza Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Equine Influenza Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Equine Influenza Vaccine Sales Market Share by Type in 2025
Figure 14. Global Equine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Equine Influenza Vaccine Consumed in Home
Figure 16. Global Equine Influenza Vaccine Market: Home (2020-2025) & (K Doses)
Figure 17. Equine Influenza Vaccine Consumed in Pet Clinic
Figure 18. Global Equine Influenza Vaccine Market: Pet Clinic (2020-2025) & (K Doses)
Figure 19. Equine Influenza Vaccine Consumed in Others
Figure 20. Global Equine Influenza Vaccine Market: Others (2020-2025) & (K Doses)
Figure 21. Global Equine Influenza Vaccine Sale Market Share by Application (2024)
Figure 22. Global Equine Influenza Vaccine Revenue Market Share by Application in 2025
Figure 23. Equine Influenza Vaccine Sales by Company in 2025 (K Doses)
Figure 24. Global Equine Influenza Vaccine Sales Market Share by Company in 2025
Figure 25. Equine Influenza Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Equine Influenza Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Equine Influenza Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 30. Americas Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 32. APAC Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 34. Europe Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Equine Influenza Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Equine Influenza Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Equine Influenza Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Equine Influenza Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Equine Influenza Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Equine Influenza Vaccine
Figure 75. Industry Chain Structure of Equine Influenza Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Equine Influenza Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Equine Influenza Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Equine Influenza Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Equine Influenza Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Equine Influenza Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Equine Influenza Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Equine Influenza Vaccine
Figure 2. Equine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Influenza Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Equine Influenza Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Equine Influenza Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Equine Influenza Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Equine Influenza Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Equine Influenza Vaccine Sales Market Share by Type in 2025
Figure 14. Global Equine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Equine Influenza Vaccine Consumed in Home
Figure 16. Global Equine Influenza Vaccine Market: Home (2020-2025) & (K Doses)
Figure 17. Equine Influenza Vaccine Consumed in Pet Clinic
Figure 18. Global Equine Influenza Vaccine Market: Pet Clinic (2020-2025) & (K Doses)
Figure 19. Equine Influenza Vaccine Consumed in Others
Figure 20. Global Equine Influenza Vaccine Market: Others (2020-2025) & (K Doses)
Figure 21. Global Equine Influenza Vaccine Sale Market Share by Application (2024)
Figure 22. Global Equine Influenza Vaccine Revenue Market Share by Application in 2025
Figure 23. Equine Influenza Vaccine Sales by Company in 2025 (K Doses)
Figure 24. Global Equine Influenza Vaccine Sales Market Share by Company in 2025
Figure 25. Equine Influenza Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Equine Influenza Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Equine Influenza Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Equine Influenza Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 30. Americas Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 32. APAC Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 34. Europe Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Equine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Equine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Equine Influenza Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Equine Influenza Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Equine Influenza Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Equine Influenza Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Equine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Equine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Equine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Equine Influenza Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Equine Influenza Vaccine
Figure 75. Industry Chain Structure of Equine Influenza Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Equine Influenza Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Equine Influenza Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Equine Influenza Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Equine Influenza Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Equine Influenza Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Equine Influenza Vaccine Revenue Market Share Forecast by Application (2026-2031)
